Trial Profile
Clinical Trials Insight: 700037958
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2009
Price :
$35
*
At a glance
- Drugs Bevirimat (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Panacos Pharmaceuticals
- 01 Dec 2009 Status changed from planning to recruiting, according to a Myriad Pharmaceuticals media release.
- 15 Oct 2008 New trial record.